CCIA
ZYME icon

Campbell & Co Investment Adviser’s Zymeworks ZYME Stock Holding History

Campbell & Co Investment Adviser’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.59M Buy
60,874
+5,991
+11% +$152K 0.08% 389
2026
Q1 		$1.37M Buy
54,883
+21,295
+63% +$504K 0.08% 390
2025
Q4 		$884K Buy
33,588
+1,095
+3% +$23.9K 0.04% 612
2025
Q3 		$555K Buy
32,493
+17,508
+117% +$251K 0.04% 686
2025
Q2 		$188K Buy
+14,985
New +$179K 0.01% 1064
2024
Q3 		– Sell
-30,363
Closed -$258K – 1379
2024
Q2 		$258K Buy
+30,363
New +$270K 0.02% 885

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Campbell & Co Investment Adviser's ZYME Position: Q2 2026 in Review

Campbell & Co Investment Adviser increased its Zymeworks (ZYME) stake by 11% in Q2 2026, buying an estimated $152K and bringing the position to 60,874 shares worth $1.59M. The position accounts for 0.08% of the portfolio, ranked #389.

Campbell & Co Investment Adviser first reported a position in ZYME in Q2 2024 and has held it in 6 quarters since. 202 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

  • Campbell & Co Investment Adviser held 60,874 shares of Zymeworks worth $1.59M as of Q2 2026.
  • Campbell & Co Investment Adviser bought 5,991 Zymeworks shares in Q2 2026, an estimated $152K.
  • Zymeworks made up 0.08% of Campbell & Co Investment Adviser's portfolio in Q2 2026, its #389 holding.
  • Campbell & Co Investment Adviser first reported a position in Zymeworks in Q2 2024 and has held it in 6 quarters since.
  • 202 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2026, filed 3 Aug 2026.